Events

There is a very strong global optimism regarding the immediate future of cell and gene therapy and the UK Ecosystem

Involving patients in the development of ATMPs is a key part of improving outcomes for patients. This webinar explores the

The presentation focuses on the impact that the work of UK Advanced Therapies has had including a number of case

Patient-reported outcomes (PROs) are increasingly used in research and routine clinical care to provide evidence of the benefits and risks

The quality and safety of Advanced Therapy Medicinal Products (ATMPs) are contingent on that of their starting materials, particularly where